Home » Trubion, Facet Collaborate on Leukemia Drug
Trubion, Facet Collaborate on Leukemia Drug
Facet Biotech Corporation and Trubion Pharmaceuticals announce an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia.
MSN Money
MSN Money
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May